Nitrated fatty acids suppress angiotensin II-mediated fibrotic remodelling and atrial fibrillation

Abstract

OA-NO2 potently inhibits atrial fibrosis and subsequent AF. Nitro-fatty acids and possibly other lipid electrophiles thus emerge as potential therapeutic agents for AF, either by increasing endogenous levels through dietary modulation or by administration as synthetic drugs.